Barriers and facilitators to HPV vaccination in primary care practices: a mixed methods study using the Consolidated Framework for Implementation Research

BACKGROUND: In the United States, the effective, safe huma papilloma virus (HPV) vaccine is underused and opportunities to prevent cancer continue to be missed. National guidelines recommend completing the 2–3 dose HPV vaccine series by age 13, well before exposure to the sexually transmitted virus....

Descripción completa

Detalles Bibliográficos
Autores principales: Garbutt, Jane M., Dodd, Sherry, Walling, Emily, Lee, Amanda A., Kulka, Katharine, Lobb, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938801/
https://www.ncbi.nlm.nih.gov/pubmed/29734944
http://dx.doi.org/10.1186/s12875-018-0750-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938801/
https://www.ncbi.nlm.nih.gov/pubmed/29734944
http://dx.doi.org/10.1186/s12875-018-0750-5

Ejemplares similares